The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease and heart failure

Clinical experience with a novel large bore vascular closure device after transfemoral transcatheter aortic valve replacement

EuroIntervention 2020;16:262-265. DOI: 10.4244/EIJ-D-19-00523

1. Department of Cardiovascular Surgery, INSURE (Institute for Translational Cardiac Surgery), German Heart Center, TUM, Munich, Germany; 2. Department of Cardiovascular Surgery, German Heart Center Munich, TUM, Munich, Germany; 3. Department of Anaesthesiology, German Heart Center Munich, TUM, Munich, Germany; 4. Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany


Introduction

Utilisation of transcatheter aortic valve replacement (TAVR) is increasing. Vascular complications after transfemoral TAVR are still of concern. The majority are related to the large bore puncture site1. Currently, large bore arteriotomy closure relies on suture-based techniques, such as the Perclose ProGlide® or Prostar® XL devices (Abbott Vascular, Santa Clara, CA, USA). Closure devices such as MANTA® (Teleflex, Wayne, PA, USA) or PerQSeal® (Vivasure Medical, Galway, Ireland) are designed to seal large bore arteriotomies and have recently become available. The novel InClosure® vascular closure device (VCD) (InSeal Medical, Caesarea, Israel) provides haemostasis ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Percutaneous access and closure using the MANTA vascular closure device in transaxillary transcatheter aortic valve implantation